Description

FLOX-0-ZOLE TABLET is a dual-action antimicrobial formulation that combines the potent fluoroquinolone Ofloxacin with the nitroimidazole derivative Ornidazole. This unique combination targets both aerobic and anaerobic bacteria, as well as protozoal pathogens, making it ideal for treating complex gastrointestinal, gynecological, dental, and genitourinary infections.

• Ofloxacin works by inhibiting bacterial DNA gyrase, disrupting DNA replication and leading to cell death in susceptible bacteria.

• Ornidazole is effective against anaerobic bacteria and protozoa. It functions by damaging DNA structures in these microorganisms, inhibiting their growth.

• Diarrhea and dysentery of mixed origin

• Amoebiasis and giardiasis

• Pelvic inflammatory disease

• Post-surgical infections

• Periodontitis and dental infections

• Vaginal and urinary tract infections

• Mixed aerobic and anaerobic infections

• Comprehensive antimicrobial spectrum

• Rapid action with high tissue penetration

• Reduces the need for multiple antibiotics

• High patient compliance due to combination therapy

Available in oral tablet form, FLOX-0-ZOLE is usually administered under medical supervision based on the nature and severity of the infection.

Manufactured in certified facilities under WHO-GMP and ISO-compliant protocols, FLOX-0-ZOLE TABLET ensures global quality standards for efficacy and safety. It is made available worldwide by BLUEPILL EXPRESS, a recognized name in third-party pharmaceutical manufacturing and international bulk supply.

BLUEPILL EXPRESS, as a merchant exporter and contract manufacturer, delivers this product to clients across Latin America, Africa, Southeast Asia, and the Middle East—ensuring availability of reliable treatments in every corner of the world.